Summary ?
GeneID6449
SymbolSGTA
SynonymsSGT|alphaSGT|hSGT
Descriptionsmall glutamine rich tetratricopeptide repeat containing alpha
ReferenceMIM:603419|HGNC:HGNC:10819|Ensembl:ENSG00000104969|HPRD:04568|Vega:OTTHUMG00000180474
Gene typeprotein-coding
Map location19p13
Pascal p-value1.26E-4
Sherlock p-value0.995
Fetal beta0.443
DMG1 (# studies)
eGeneMyers' cis & trans

Gene in Data Sources
Gene set name Method of gene setDescriptionInfo
CV:PGCnpGenome-wide Association StudyGWAS
DMG:Jaffe_2016Genome-wide DNA methylation analysisThis dataset includes 2,104 probes/CpGs associated with SZ patients (n=108) compared to 136 controls at Bonferroni-adjusted P < 0.05. 1

Section I. Genetics and epigenetics annotation

@Differentially methylated gene

ProbeChromosomePositionNearest geneP (dis)Beta (dis)FDR (dis)Study
cg19693284192783607SGTA2.01E-8-0.0116.99E-6DMG:Jaffe_2016

@eQTL annotation

SNP IDChromosomePositioneGeneGene Entrez IDpvalueqvalueTSS distanceeQTL type
rs7670908chr4110892624SGTA64490.09trans
rs9991367chr4110894300SGTA64490.09trans
rs1578978chr8118196802SGTA64490.09trans

Section II. Transcriptome annotation

General gene expression (GTEx)

Not available

Gene expression during devlopment (BrainCloud)

Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.

Gene expression of temporal and spatial changes (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.

No co-expressed genes in brain regions


Section IV. Protein-protein interaction annotation

InteractorsAliases BOfficial full name BExperimentalSourcePubMed ID
C1QTNF1CTRP1 | FLJ90694 | GIP | ZSIG37C1q and tumor necrosis factor related protein 1Two-hybridBioGRID16189514 
EFEMP1DHRD | DRAD | FBLN3 | FBNL | FLJ35535 | MGC111353 | MLVT | MTLV | S1-5EGF-containing fibulin-like extracellular matrix protein 1Two-hybridBioGRID16189514 
EFEMP2FBLN4 | MBP1 | UPH1EGF-containing fibulin-like extracellular matrix protein 2Two-hybridBioGRID16189514 
F11RCD321 | JAM | JAM-1 | JAM-A | JAM1 | JAMA | JCAM | KAT | PAM-1F11 receptorTwo-hybridBioGRID16189514 
GHRGHBPgrowth hormone receptor-HPRD,BioGRID12735788 
GPX7CL683 | FLJ14777 | GPX6 | NPGPxglutathione peroxidase 7Two-hybridBioGRID16189514 
HSP90AA1FLJ31884 | HSP86 | HSP89A | HSP90A | HSP90N | HSPC1 | HSPCA | HSPCAL1 | HSPCAL4 | HSPN | Hsp89 | Hsp90 | LAP2heat shock protein 90kDa alpha (cytosolic), class A member 1-HPRD,BioGRID12482202 
HSPA4APG-2 | HS24/P52 | MGC131852 | RY | hsp70 | hsp70RYheat shock 70kDa protein 4Far WesternBioGRID12482202 
IGLC1IGLCimmunoglobulin lambda constant 1 (Mcg marker)Two-hybridBioGRID16189514 
MSTNGDF8myostatinhSGT interacts with the amino terminal region of myostatin.BIND14623262 
NME3DR-nm23 | KIAA0516 | NDPK-C | NDPKC | NM23-H3 | c371H6.2non-metastatic cells 3, protein expressed inTwo-hybridBioGRID16189514 
PFN2D3S1319E | PFLprofilin 2Two-hybridBioGRID16169070 
PTNHARP | HBGF8 | HBNF | NEGF1pleiotrophinTwo-hybridBioGRID16169070 
SGTASGT | alphaSGT | hSGTsmall glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha-HPRD9557704 
SPP1BNSP | BSPI | ETA-1 | MGC110940 | OPNsecreted phosphoprotein 1Two-hybridBioGRID16189514 
SPPL2AIMP3 | PSL2signal peptide peptidase-like 2ATwo-hybridBioGRID16189514 
SRGNFLJ12930 | MGC9289 | PPG | PRG | PRG1serglycinTwo-hybridBioGRID16189514 
SYT4HsT1192 | KIAA1342synaptotagmin IVTwo-hybridBioGRID16189514 
ZG16MGC34820zymogen granule protein 16Two-hybridBioGRID16189514 


Section V. Pathway annotation

Pathway namePathway size# SZGR 2.0 genes in pathwayInfo
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP 579346All SZGR 2.0 genes in this pathway
DOANE RESPONSE TO ANDROGEN DN 241146All SZGR 2.0 genes in this pathway
DARWICHE PAPILLOMA PROGRESSION RISK 7444All SZGR 2.0 genes in this pathway
SCHLOSSER MYC AND SERUM RESPONSE SYNERGY 3222All SZGR 2.0 genes in this pathway
DARWICHE PAPILLOMA RISK HIGH VS LOW DN 3221All SZGR 2.0 genes in this pathway
DAIRKEE TERT TARGETS UP 380213All SZGR 2.0 genes in this pathway
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UP 479299All SZGR 2.0 genes in this pathway
BENPORATH SOX2 TARGETS 734436All SZGR 2.0 genes in this pathway
NING CHRONIC OBSTRUCTIVE PULMONARY DISEASE UP 157105All SZGR 2.0 genes in this pathway
PENG GLUTAMINE DEPRIVATION DN 337230All SZGR 2.0 genes in this pathway
BLALOCK ALZHEIMERS DISEASE UP 16911088All SZGR 2.0 genes in this pathway
KIM GASTRIC CANCER CHEMOSENSITIVITY 10364All SZGR 2.0 genes in this pathway
CUI TCF21 TARGETS 2 UP 428266All SZGR 2.0 genes in this pathway
DOUGLAS BMI1 TARGETS UP 566371All SZGR 2.0 genes in this pathway
GRADE COLON CANCER UP 871505All SZGR 2.0 genes in this pathway
MOOTHA PGC 420269All SZGR 2.0 genes in this pathway